Last updated: 24 May 2024 at 7:45pm EST

Heidi Fields Net Worth




The estimated Net Worth of Heidi Fields is at least $6.04 Million dollars as of 5 March 2024. Heidi Fields owns over 1,658 units of Avanos Medical Inc stock worth over $1,292,462 and over the last 21 years Heidi sold AVNS stock worth over $4,744,146.

Heidi Fields AVNS stock SEC Form 4 insiders trading

Heidi has made over 25 trades of the Avanos Medical Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently Heidi sold 1,658 units of AVNS stock worth $239,316 on 5 March 2024.

The largest trade Heidi's ever made was selling 30,000 units of Avanos Medical Inc stock on 31 March 2016 worth over $1,197,300. On average, Heidi trades about 2,323 units every 83 days since 2004. As of 5 March 2024 Heidi still owns at least 54,975 units of Avanos Medical Inc stock.

You can see the complete history of Heidi Fields stock trades at the bottom of the page.



What's Heidi Fields's mailing address?

Heidi's mailing address filed with the SEC is C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK, NJ, 07932.

Insiders trading at Avanos Medical Inc

Over the last 6 years, insiders at Avanos Medical Inc have traded over $152,960 worth of Avanos Medical Inc stock and bought 24,500 units worth $834,605 . The most active insiders traders include Heidi Fields, Julie Ann Shimer, and Patrick J Oleary. On average, Avanos Medical Inc executives and independent directors trade stock every 194 days with the average trade being worth of $129,470. The most recent stock trade was executed by Michael Greiner on 18 March 2024, trading 4,219 units of AVNS stock currently worth $99,189.



What does Avanos Medical Inc do?

avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.headquartered in alpharetta, georgia, avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.avanos develops, manufactures and markets its recognized brands in more than 90 countries.



Complete history of Heidi Fields stock trades at Agilent Technologies, Phathom Pharmaceuticals Inc, and Avanos Medical Inc

Insider
Trans.
Transaction
Total value
Heidi Fields
Director
Sale $239,316
5 Mar 2024
Heidi Fields
Director
Sale $566,478
23 Nov 2022
Heidi Fields
Director
Sale $945,672
4 Jun 2020
Heidi Fields
Director
Sale $314,240
20 Sep 2019
Heidi Fields
Director
Sale $283,840
30 Aug 2019
Heidi Fields
Director
Option $76,145
11 Sep 2018
Heidi Fields
Director
Option $69,450
11 Jun 2018
Heidi Fields
Director
Option $69,450
27 Mar 2018
Heidi Fields
Director
Option $225,630
16 Jun 2017
Heidi Fields
Director
Option $195,504
6 Sep 2016
Heidi Fields
Director
Option $195,504
6 Sep 2016
Heidi Fields
Director
Sale $1,197,300
31 Mar 2016
Heidi Fields
Director
Sale $1,197,300
31 Mar 2016
Heidi Fields
Director
Option $214,211
4 Nov 2015
Heidi Fields
Director
Option $109,295
30 Sep 2014
Heidi Fields
Director
Option $112,234
21 Feb 2014
Heidi Fields
Director
Option $124,986
28 Sep 2012
Heidi Fields
Director
Buy $65,304
16 Aug 2012
Heidi Fields
Director
Option $147,549
30 Dec 2011
Heidi Fields
Director
Option $144,413
20 Dec 2010
Heidi Fields
Director
Buy $18,069
1 Nov 2006


Avanos Medical Inc executives and stock owners

Avanos Medical Inc executives and other stock owners filed with the SEC include: